Australis Cap Stock Price, News & Analysis
Company Description
Australis Cap (OTC Link: AUSAF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $5.8M.
AUSAF stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of AUSAF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Australis Cap (AUSAF) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $5.8M, AUSAF is classified as a micro-cap stock with approximately 301.2M shares outstanding.
Latest News
Australis Cap has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, management. View all AUSAF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Australis Cap (AUSAF) currently stands at 1.1 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Australis Cap (AUSAF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
AUSAF Company Profile & Sector Positioning
Australis Cap (AUSAF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing AUSAF often look at related companies in the same sector, including Bakhu Hold (BKUH), Elixinol Wellness Limited (ELLXF), Cls Holdings Usa (CLSH), Pharmacielo (PCLOF), and Stemsation International Inc (STSN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AUSAF's relative position within its industry.